Joint Statement by Members of the NCCN Prostate Cancer Guidelines Panel

View More View Less
Restricted access

James L. Mohler, MD, is Associate Director for Translational Research and Senior Vice President, Chair of the Department of Urology, and Professor of Oncology at Roswell Park Cancer Institute. He is also Professor of Urology at the University at Buffalo School of Medicine and Biomedical Sciences and maintains academic appointments at UNC-Lineberger Comprehensive Cancer Center.

He is a Diplomate of the National Board of Medical Examiners and American Board of Urology and a Fellow of the American College of Surgeons. Dr. Mohler is Chair of the NCCN Prostate Cancer Guidelines Panel, Vice-Chair of the Genitourinary Committee of the Alliance for Clinical Trials in Oncology, and Past-President of the Society for Basic Urologic Research. His professional society memberships include AMA, American Urological Association, and American College of Surgeons.

Dr. Mohler’s clinical practice focuses on prostate cancer and robot-assisted laparoscopic surgery. His laboratory focuses on the role of the androgen receptor in racial differences in prostate cancer aggressiveness and recurrence during androgen deprivation therapy. He has authored or co-authored more than 150 publications, including a book on the androgen axis in prostate cancer.

This statement was delivered on behalf of NCCN on October 25, 2013, by James L. Mohler, MD, Roswell Park Cancer Institute, Chair of the NCCN Prostate Cancer Guidelines Panel. It was first published on NCCN.org, and is available at http://www.nccn.org/professionals/meetings/oncology_policy_program/article/nejm.aspx.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 42 26 2
PDF Downloads 10 7 1
EPUB Downloads 0 0 0